Virna Cerasoli

Istituti di Ricovero e Cura a Carattere Scientifico

Papers

1

Total Citations

15

H-Index

1

About

Dr. Virna Cerasoli is a leading thoracic surgeon whose research focuses on advancing minimally invasive surgical techniques for lung cancer treatment, particularly through robotic-assisted approaches. Her landmark 2022 study, "Oncological Outcomes of Robotic Lobectomy and Radical Lymphadenectomy for Early-Stage Non-Small Cell Lung Cancer," has garnered 15 citations and provides critical evidence supporting robotic surgery as a safe and effective alternative to traditional thoracotomy for early-stage disease. This work demonstrates that robotic lobectomy achieves comparable oncological outcomes while offering patients improved peri-operative recovery, shorter hospital stays, and reduced morbidity. Dr. Cerasoli’s contributions are helping to shift the surgical paradigm away from the once-gold-standard open approach, establishing robotic techniques as a cornerstone of modern lung cancer care. Her research is particularly valuable for surgeons and oncologists seeking to optimize treatment pathways, and her findings continue to influence clinical guidelines. By rigorously documenting surgical outcomes, Dr. Cerasoli is paving the way for broader adoption of robotic surgery, ultimately improving quality of life for lung cancer patients worldwide.

Research Focus

Key Achievements

1
H-Index
1
Papers
15
Total Citations
15
Avg Citations/Paper
🏆 Most Cited Paper
Oncological Outcomes of Robotic Lobectomy and Radical Lymphadenectomy for Early-Stage Non-Small Cell Lung Cancer
15 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Istituti di Ricovero e Cura a Carattere Scientifico

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago